Agios Pharmaceuticals

The Best Performing Biotech Stocks of 2014: Amazing 300% Gainers
24/7 Wall St
Tue, 12/30/14 - 10:21 am
Agios Pharmaceuticals
OvaScience
Radius
Prosensa
TG Therapeutics
Bluebird Bio
Receptos
Best and worst 2014 biotech performers on Wall Street
Fierce Biotech
Tue, 12/23/14 - 10:24 am
Avanir Pharmaceuticals
Agios Pharmaceuticals
TG Therapeutics
Bluebird Bio
Vivus
Agerion
Theravance
The Winners for Best and Worst Biotech CEOs of 2014 Are...
TheStreet.com
Thu, 12/18/14 - 11:25 am
biotech
Bluebird Bio
Agios Pharmaceuticals
The Nominees for Best Biotechnology Co. CEO of 2014 Are...
TheStreet.com
Fri, 12/12/14 - 09:37 am
biotech
EXACT Sciences
Idenix
Prosensa
Agios Pharmaceuticals
Bluebird Bio
InterMune
These 4 Biotech Stocks Have Been On Fire
Yahoo/Benzinga
Mon, 12/8/14 - 11:12 pm
Agios Pharmaceuticals
Achillion
Amicus Therapeutics
Orexigen
The 7 Most Important Drug-Stock Lessons From This Weekend's Blood Cancer Meeting
TheStreet.com
Mon, 12/8/14 - 10:30 am
Agios Pharmaceuticals
Novartis
CAR-T
Celgene
Amgen
Merck
Bristol-Myers Squibb
Seattle Genetics
Sunesis
Hot Drugmakers Build More Labs, Grab Space In Boston
Investors.com
Thu, 12/4/14 - 05:41 pm
Boston
Biogen Idec
Baxter International
Agios Pharmaceuticals
Pfizer
Agios Cancer 'Metabolism' Drug Clears Bone Marrow of Leukemic Cells
TheStreet.com
Wed, 11/19/14 - 08:30 am
Agios Pharmaceuticals
leukemia
AG-120
AML
Agios' Early Drug-Trial Report Cheers Wall Street
Investors.com
Fri, 09/26/14 - 03:57 pm
Agios Pharmaceuticals
AG-120
Agios Pharmaceuticals announces AG-221 orphan drug designation
Yahoo/The Fly on the Wall
Mon, 06/16/14 - 09:58 am
Agios Pharmaceuticals
AG-221
acute myelogenous leukemia
leukemia
New Agios Clinical Data from Ongoing Phase 1 Trial of AG-221 Continue to Show Complete and Durable Remissions in Patients with Difficult to Treat Hematologic Malignancies
Yahoo/BusinessWire
Sat, 06/14/14 - 09:27 am
hematologic cancers
Agios Pharmaceuticals
AG-221
This Week in Biotech: The Questcor Buyout and MannKind's Giant Leap to Nowhere
Motley Fool
Sun, 04/13/14 - 10:14 am
Questcor
MannKind
Agios Pharmaceuticals
Mallinckrodt
Alkermes
Merck
3 Stocks That Escaped Biotech's March Madness
Motley Fool
Fri, 04/4/14 - 09:27 am
Agios Pharmaceuticals
Chimerix
Portola Pharmaceuticals
Agios advances cancer metabolism collaboration with Celgene
Yahoo/Fly on the Wall
Wed, 12/11/13 - 09:35 am
Agios Pharmaceuticals
Celgene
cancer metabolism
Biotech IPOs Are Back To Normal
Seeking Alpha
Tue, 11/26/13 - 08:51 am
biotech
IPOs
Agios Pharmaceuticals
Omthera
Relypsa
David Schenkein, Cancer Doc Turned CEO, Aims to Build New Genentech
Xconomy
Thu, 10/17/13 - 08:36 am
David Schenkein
Agios Pharmaceuticals
Genentech
Celgene pays Agios $20M to extend cancer drug pact
Yahoo/AP
Wed, 10/5/11 - 10:51 am
Celgene
Agios Pharmaceuticals
cancer
Celgene deal means $130m for Agios
Boston.com
Thu, 04/15/10 - 09:53 am
Celgene
Agios Pharmaceuticals
The 15 most promising biotech companies
Fierce Pharma
Mon, 06/29/09 - 03:41 pm
biotech
Achaogen
Agios Pharmaceuticals
Aileron
BioVex
Calistoga Pharmaceuticals
Clovis Oncology
Heptares Therapeutics
Ironwood
iZumi Bio
KaloBios
Pacific Biosciences
Portola Pharmaceuticals
Proteon Therapeutics
VaxInnate
Zafgen

Pages